Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Illumina acquires DNA sequencer Pacific Bio

Executive Summary

Illumina Inc. acquired "long-read" DNA sequencing company Pacific Biosciences of California Inc. for $8 per share in cash (89% premium to the prior 10-day trading average), or a fully diluted equity value of $1.2bn (taking into account cash and debt enterprise value of $1.1bn; sales multiple of 12.7x) .
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Nanotechnology, Chips, etc.
    • Pharmacogenetics-Pharmacogenomics
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Intra-Biotech Deal
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register